Search
Close this search box.

Latest News

August 2024: New ADS Guideline and Consensus Statement


Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024)

A joint guideline by the Australian Diabetes Society (ADS) and Australian and New Zealand Society of Nuclear Medicine (ANZSNM) for PET/CT imaging in patients with type 1 and type 2 diabetes.

The purpose of the guideline is to assist medical, nursing and nuclear medicine staff to prepare and manage people living with diabetes undergoing a PET scan. This guideline is for the provision of advice only and does not replace clinical decision making in individual patients or specific protocols adapted for individual centres.

Download the Joint ADS/ANZSNM guideline for FDG PET/CT imaging in patients with type 1 and type 2 diabetes (August 2024)




Consensus Statement: The Use of Diabetes Specific Nutritional Formulas in Type 2 Diabetes (August 2024)

Developed by an expert working group of representatives from the Australian Diabetes Society (ADS), Australian Diabetes Educators Association (ADEA), Royal Australian College of General Practitioners (RACGP) and Dietitians Australia, this consensus statement aims to provide healthcare professionals with a comprehensive understanding of Diabetes Specific Nutritional Formulas (DSNFs) and their potential role in managing T2D, and to offer guidance for their application in clinical practice, based on a review of the current evidence as well as expert opinions.

This consensus statement has been written for healthcare professionals who manage people with type 2 diabetes (T2D), including general practitioners (GPs) and other primary healthcare team members.

Download the Consensus Statement: The Use of Diabetes Specific Nutritional Formulas in Type 2 Diabetes (August 2024)